4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2H)-pyridazinone hydrochloride,
NM-702,
NT 702,
NT-702,
NT702 cpd,
parogrelil hydrochloride,
Parogrelil,
139145-27-0,
UNII-2PCP9N33NH,
2PCP9N33NH,
4-Bromo-6-(3-(4-chlorophenyl)propoxy)-5-((pyridin-3-ylmethyl)amino)pyridazin-3(2H)-one,
Parogrelil [INN],
NM 702,
NT 702, free base,
MLS006010243,
SCHEMBL149290,
YJMYSLFFZJUXOA-UHFFFAOYSA-N,
BCPP000130,
BCP02174,
ZINC1539352,
NT-702,
AKOS027338693,
API0013700,
BCP9001051,
SB16958,
NCGC00346449-01,
NCGC00346449-02,
4CA-0965,
AN-31800,
SMR004701319,
145P270,
4-bromo-5-(3-pyridylmethylamino)-6-(3-(4-chlorophenyl) propoxy)-3-(2H)pyridazinone,
4-Bromo-5-[(3-pyridyl)methylamino]-6-[3-(4-chlorophenyl)propoxy]pyridazine-3(2H)-one,
5-bromo-3-[3-(4-chlorophenyl)propoxy]-4-(3-pyridylmethylamino)-1H-pyridazin-6-one,
4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(pyridin-3-ylmethyl)amino]-2,3-dihydropyridazin-3-one,
CID9803788,
4-Bromo-6-[3- propoxy]-5- pyridazin-3 -onehydrochloride,
4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)-2H-pyridazin-3-one,
4-Bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2H)-one hydrochloride (free base),